🇺🇸 FDA
Pipeline program

Remifentanil

CIRB/2015/2352

Approved small_molecule active

Quick answer

Remifentanil for Labor Pain is a Approved program (small_molecule) at Hospital Authority, Hong Kong with 1 ClinicalTrials.gov record(s).

Program details

Company
Hospital Authority, Hong Kong
Indication
Labor Pain
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials